Mpox Biology, Outcome, Transmission and Epidemiology
NCT06652646 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-10-22
Summary
The MBOTE-Kamituga clinical and virological characterization protocol is a prospective observational cohort study with clinical and virological description of suspected mpox cases and longitudinal follow-up of confirmed mpox cases. Research activities will be aligned as far as possible with the response to the epidemic.
Conditions
- Mpox (Monkeypox)
Sponsors & Collaborators
-
Ministry of Public Health, Democratic Republic of the Congo
collaborator OTHER_GOV -
Research Foundation Flanders
collaborator OTHER -
National Institutes of Health (NIH)
collaborator NIH -
Institute of Tropical Medicine, Belgium
lead OTHER
Principal Investigators
-
Laurens Liesenborghs · Institute of Tropical Medicine
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-05-31
- Completion
- 2025-05-31
Countries
- Democratic Republic of the Congo
Study Locations
More Related Trials
-
Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks
NCT06887556 ·Status: RECRUITING ·Phase: NA
-
Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response
NCT04250168 ·Status: TERMINATED
-
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
NCT05422963 ·Status: UNKNOWN
-
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC
NCT04235361 ·Status: UNKNOWN
-
Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.
NCT07174648 ·Status: NOT_YET_RECRUITING
-
A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis
NCT06007326 ·Status: COMPLETED
-
French COVID Cohort
NCT04262921 ·Status: ACTIVE_NOT_RECRUITING
-
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
NCT03662022 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region
NCT07017803 ·Status: NOT_YET_RECRUITING
-
COVID-19 STAndard of Care in Sub-Saharan Africa
NCT04885543 ·Status: COMPLETED
-
B-PaLMZ for TB Meningitis
NCT07227779 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
NCT01359358 ·Status: UNKNOWN
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
Surveillance of AMR in DRC
NCT06821282 ·Status: RECRUITING
-
Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
NCT06305468 ·Status: RECRUITING
-
Seroepidemiological Investigation of Coronavirus 2019 (COVID-19) Infection in Gabon
NCT05065632 ·Status: UNKNOWN
-
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
NCT00631566 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
NCT04537663 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
NCT01589289 ·Status: COMPLETED ·Phase: PHASE3
-
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
NCT05597280 ·Status: RECRUITING ·Phase: PHASE3
-
BTZ-043 Dose Evaluation in Combination and Selection
NCT05926466 ·Status: RECRUITING ·Phase: PHASE2
-
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
NCT03338621 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Feasibility and Usability of COVID-19 Antigen RDTs in Uganda
NCT05630300 ·Status: COMPLETED ·Phase: NA
-
PanACEA Sutezolid Dose-finding and Combination Evaluation
NCT03959566 ·Status: COMPLETED ·Phase: PHASE2